NYSE:TXMD
TherapeuticsMD Stock News
$2.22
+0.100 (+4.72%)
At Close: May 17, 2024
TherapeuticsMD to Report Second Quarter 2022 Financial Results on August 15, 2022
06:50am, Monday, 08'th Aug 2022
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced that it will report its sec
Why TherapeuticsMD Shares Are Sinking Today?
09:59am, Wednesday, 13'th Jul 2022
Women's healthcare company TherapeuticsMD Inc (NASDAQ: TXMD) shares are falling as EW Healthcare Partners did not acquire the required majority of shares of TXMD through the previously announced
TherapeuticsMD's stock falls 41% after tender offer expires
08:25am, Wednesday, 13'th Jul 2022
Shares of TherapeuticsMD Inc. TXMD, +8.67% tumbled 41.6% in premarket trading on Wednesday after the women's health company told investors that EW Healthcare Partners' planned acquisition of Therapeut
5 Short Squeeze Candidates To Watch This Week: Revlon Tops The List, A SPAC Shifts To Second And More
12:01pm, Tuesday, 21'st Jun 2022
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.
TherapeuticsMD: Privatization Deal Expected To Meet With Shareholder Pushback
02:43pm, Thursday, 16'th Jun 2022
TherapeuticsMD's $177 million buyout deal with EW Healthcare largely undervalues the biotech. TherapeuticsMD is close to stimulating the commercialization of Annovera which may increase its value as a
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.
Why EW Healthcare Partners Is Buying TherapeuticsMD (TXMD) In A $177 Million Deal
02:47pm, Tuesday, 31'st May 2022
TherapeuticsMD, Inc. (NASDAQ: TXMD) announced it entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners as part of a $177 million deal. These are the detai
Here is why TherapeuticsMD jumped 300%
01:57pm, Tuesday, 31'st May 2022
TherapeuticsMD Inc. (NASDAQ: TXMD) surged 300% after the women's healthcare firm announced the signing of a definitive agreement to be purchased by an EW Healthcare Partners affiliate. EW Healthcare P
Why TherapeuticsMD Stock Is Soaring Today
10:12am, Tuesday, 31'st May 2022
TherapeuticsMD Inc (NASDAQ: TXMD) shares are surging Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners. E
Hot Biotech Penny Stocks to Watch as Stocks Enter Bear Market
06:11pm, Friday, 20'th May 2022
Are these biotech penny stocks on your watchlist right now? The post Hot Biotech Penny Stocks to Watch as Stocks Enter Bear Market appeared first on Penny Stocks to Buy, Picks, News and Information
Why TherapeuticsMD Shares Are Trading Higher Today
10:54am, Friday, 20'th May 2022
TherapeuticsMD Inc (NASDAQ: TXMD) shares are trading higher after FDA approved the supplemental application, including minor revisions to Annovera's in vitro release testing specification that all
TherapeuticsMD, Inc. (TXMD) CEO Hugh O'Dowd on Q1 2022 Results - Earnings Call Transcript
08:07pm, Monday, 16'th May 2022
TherapeuticsMD, Inc. (NASDAQ:TXMD ) Q1 2022 Earnings Conference Call May 16, 2022 4:30 PM ET Company Participants Lisa Wilson - IR Hugh O'Dowd - CEO Michael Donegan - Interim CFO Mark Glickman - Chief
TherapeuticsMD (TXMD) Reports Q1 Loss, Misses Revenue Estimates
06:48pm, Monday, 16'th May 2022
TherapeuticsMD (TXMD) delivered earnings and revenue surprises of -34.86% and 1.41%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022
04:05pm, Tuesday, 10'th May 2022
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced that it will report its fir
TherapeuticsMD (TXMD) Stock: 1-For-50 Reverse Split Goes Into Effect
06:48am, Monday, 09'th May 2022
The TherapeuticsMD Inc (NASDAQ: TXMD) board has completed a 1-for-50 reverse stock split. These are the details.